Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 04 November, 2019

Morgan Stanley Cap

Rule 38.5 - ABBVIE INC.

RNS Number : 1456S
Morgan Stanley Capital Services LLC
04 November 2019
 

 

 FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.             KEY INFORMATION

 Name of exempt market-maker

   Morgan Stanley Capital Services LLC

 Company dealt in

   ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

   01 NOVEMBER 2019

 

 

2.             DEALINGS (Note 2)

 

(a)           Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  62,719

 81.9200 USD

 79.8500 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  59,364

 82.0950 USD

 79.5500 USD

 

 

(b)           Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

                (Note 4)

 Number of relevant securities

                (Note 5)

 Price per unit

CFD

LONG

10,000

80.0000 USD

CFD

LONG

400

80.6000 USD

CFD

LONG

469

81.1845 USD

CFD

LONG

100

81.4300 USD

CFD

LONG

51

81.5900 USD

CFD

LONG

2,857

81.6593 USD

CFD

LONG

37,600

81.6634 USD

CFD

LONG

129

81.7244 USD

CFD

LONG

63

81.7500 USD

CFD

LONG

499

81.8042 USD

CFD

LONG

5,955

81.9512 USD

CFD

LONG

210

82.0045 USD

CFD

SHORT

127

80.1753 USD

CFD

SHORT

18,186

80.8983 USD

CFD

SHORT

129

81.3100 USD

CFD

SHORT

167

81.3900 USD

CFD

SHORT

43

81.4533 USD

CFD

SHORT

173

81.4842 USD

CFD

SHORT

7,500

81.6635 USD

CFD

SHORT

13,600

81.7219 USD

CFD

SHORT

6,500

81.7234 USD

CFD

SHORT

24

81.7450 USD

CFD

SHORT

273

81.7500 USD

 

 

(c)            Options transactions in respect of existing relevant securities

 

i)           Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 04 NOVEMBER 2019

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEUSURRKRAARAA

a d v e r t i s e m e n t